NFKB1 and Parkinson disease: It has been claimed that apigenin (25 and 50 mg/kg) modifies deleterious structural and functional changes through the Nrf2 and NF-κB pathways, and attenuates LPS-induced experimental PD in rats (Patel and Singh, 2022 ▶).